19 results on '"Borsi, V."'
Search Results
2. Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study)
- Author
-
Pagani, S., Lombardi, N., Crescioli, G., Vighi, G. V., Spada, G., Romoli, I., Andreetta, P., Capuano, A., Marrazzo, E., Marra, A., Leoni, O., Vannacci, A., Venegoni, M., Vighi, G. D., Bettoni, D., Blandizzi, C., Bonaiuti, R., Borsi, V., Cecchi, E., Convertino, I., Del Lungo, M., Di Mauro, C., Farina, G., Ferraro, S., Fucile, A., Galfrascoli, E., Geninatti, E., Giovannetti, L., Leonardi, L., Liccardo, R., Monina, G., Mugelli, A., Parrilli, M., Rafaniello, C., Rossi, F., Rostan, S., Ruocco, M., Sironi, M., Sportiello, L., Tuccori, M., Pagani, S., Lombardi, N., Crescioli, G., Vighi, G. V., Spada, G., Romoli, I., Andreetta, P., Capuano, A., Marrazzo, E., Marra, A., Leoni, O., Vannacci, A., Venegoni, M., Vighi, G. D., Bettoni, D., Blandizzi, C., Bonaiuti, R., Borsi, V., Cecchi, E., Convertino, I., Del Lungo, M., Di Mauro, C., Farina, G., Ferraro, S., Fucile, A., Galfrascoli, E., Geninatti, E., Giovannetti, L., Leonardi, L., Liccardo, R., Monina, G., Mugelli, A., Parrilli, M., Rafaniello, C., Rossi, F., Rostan, S., Ruocco, M., Sironi, M., Sportiello, L., and Tuccori, M.
- Subjects
Drug ,Male ,medicine.medical_specialty ,Drug-Related Side Effects and Adverse Reactions ,media_common.quotation_subject ,Adverse drug reaction ,030204 cardiovascular system & hematology ,03 medical and health sciences ,Appropriateness of drug use ,Pharmacovigilance ,0302 clinical medicine ,Older patients ,Internal Medicine ,Medicine ,Humans ,030212 general & internal medicine ,Adverse effect ,Drug safety ,media_common ,Aged ,Medication error ,business.industry ,Public health ,Anticoagulants ,Mean age ,medicine.disease ,Italy ,Concomitant ,Emergency medicine ,Emergency Medicine ,Female ,business ,Emergency Service, Hospital ,Algorithms ,Platelet Aggregation Inhibitors - Abstract
Fatal Adverse Events (FADEs) are a major public health problem, and some FADEs could be preventable. The aim of the present study is to describe the frequency, the drugs involved and the preventability in the FADEs collected through the MEREAFaPS Study between 2012 and 2018. All cases including the outcome “death” have been examined. We excluded cases with vaccine-related ADEs, overdose or suicide, and ADEs occurred during the hospitalisation. Two trained assessors evaluated all cases fulfilling the inclusion criteria. ADEs’ preventability was evaluated applying the Schumock and Thornton algorithm. During the study period, we observed 429 cases of death, 92 of which were excluded. The remaining 337 cases involved 187 women and 150 men, with a mean age of 79 and of 77years, respectively. For each report, the suspected drugs and concomitant ones were 1.26 and 4.20, respectively. Anticoagulants and antiplatelet agents account for more than 40% of FADE cases and the most frequent reactions are haemorrhages (37.5%). The 25% of the FADEs were preventable. This study confirms that FADEs are still a relevant clinical occurrence, and are often caused by widely used old drugs associated with adverse events. The death of one in four patients was preventable. Further efforts should be done to improve the appropriateness of the therapy, especially in older patients who are treated with anticoagulants.
- Published
- 2021
3. 5PSQ-031 A two-year retrospective analysis of adverse drug reactions with fluoroquinolone and quinolone antibiotics
- Author
-
Borsi, V, primary, Del Lungo, M, additional, Giovannetti, L, additional, Lai, MG, additional, and Parrilli, M, additional
- Published
- 2019
- Full Text
- View/download PDF
4. PP-024 Evaluation of long term biological activity of pegaspargase (oncaspar) after dilution in nacl 0.9%
- Author
-
Borsi, V, primary, Calderoni, F, additional, Di Renzo, A, additional, Scala, L, additional, Scialino, G, additional, Marca, G La, additional, Ceccantini, R, additional, Di Simone, L, additional, and Calvani, AM, additional
- Published
- 2016
- Full Text
- View/download PDF
5. PP-043 Propranolol 2 mg/ml as syrup for skin angiomas. Clinical evaluation of an off-label preparation
- Author
-
Borsi, V, primary, Scala, L, additional, Scialino, G, additional, Renzi, G, additional, Mercaldo, I, additional, Greco, A, additional, Calderoni, F, additional, Di Renzo, A, additional, Di Simone, L, additional, and Calvani, AM, additional
- Published
- 2016
- Full Text
- View/download PDF
6. PP-018 Preparation of eye drops for vernal keratoconjunctivitis: the pharmacist added to a team acts as a fulcrum between doctor and patient
- Author
-
Borsi, V, primary, Sgromo, C, additional, Scala, L, additional, Scialino, G, additional, Calvani, A, additional, Di Simone, L, additional, La Marca, G, additional, Ceccantini, R, additional, Pucci, N, additional, and De Libero, C, additional
- Published
- 2015
- Full Text
- View/download PDF
7. Intermolecular/interdomain interactions in proteins
- Author
-
Borsi, V.
- Published
- 2009
8. Solution structure and dynamics of human S100A14
- Author
-
Bertini, I., primary, Borsi, V., additional, Cerofolini, L., additional, Das Gupta, S., additional, Fragai, M., additional, and Luchinat, C., additional
- Published
- 2013
- Full Text
- View/download PDF
9. Solution structure of calcium bound S100A16
- Author
-
Babini, E., primary, Bertini, I., additional, Borsi, V., additional, Calderone, V., additional, Hu, X., additional, Luchinat, C., additional, and Parigi, G., additional
- Published
- 2010
- Full Text
- View/download PDF
10. Solution structure of apo S100A16
- Author
-
Babini, E., primary, Bertini, I., additional, Borsi, V., additional, Calderone, V., additional, Hu, X., additional, Luchinat, C., additional, and Parigi, G., additional
- Published
- 2010
- Full Text
- View/download PDF
11. 5PSQ-141 Incident reporting with central venous catheters for paediatric patients: an interdisciplinary clinical pathway
- Author
-
Borsi, V, Calvani, AM, Consalvi, L, Simone, L Di, Scala, L, Scialino, G, Renzi, G, Renzo, A Di, Alunno, A, and Cosoli, F
- Abstract
BackgroundFrom January to October 2017, several departments of our hospital reported incidents involving paediatric central venous catheters (3–4 Fr) that led to invasive interventions on patients, in some cases even after their repairi by a dedicated kit. The pharmacist reported to the Ministry of Health each of the cases that occurred, communicating at the same times the events to the manufacturer and the hospital health department. A number of meetings were organised with the various departments involved, with the supplier company and with our Hospital Clinical Risk Department.PurposeThe goal was to understand the problem that led to device breaks and to create a shared pathway in order to replace them with others with characteristics that best met our needs.Material and methodsCollecting incident reports.Organising meetings with the departments involved, the manufacturer providing the device and the Clinical Risk Department.ResultsDuring the period under review there were 16 incidents with children aged between 3 months to 10 years, mainly in the departments of Oncoematology, Neonatal Intensive Care Unit, Department of Blood and Marrow Transplantation, Operating Room and Nutritional Service. Central venous catheters were used to administer chemotherapy therapies and parenteral nutrition: each one was withdrawn by the manufacturer to make the necessary investigations. Abandoning the hypothesis that the material was not suitable for the administration of certain chemotherapeutic drugs and that the problem was related to specific batches of the device itself, the decision taken by the clinicians, in accordance with pharmacists and clinical risk managers, was to replace the product, due to the number of accidents that had occurred in a few months.ConclusionThis experience demonstrates how the surveillance system is effective in responding to clinical needs when there is a strong collaboration among all involved actors.No conflict of interest
- Published
- 2018
- Full Text
- View/download PDF
12. Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study)
- Author
-
Niccolò Lombardi, Giada Crescioli, Alessandra Bettiol, Marco Tuccori, Annalisa Capuano, Roberto Bonaiuti, Alessandro Mugelli, Mauro Venegoni, Giuseppe Danilo Vighi, Alfredo Vannacci, the MEREAFaPS Study group, Maria Luisa Aiezza, Daria Bettoni, Corrado Blandizzi, Valentina Borsi, Errica Cecchi, Irma Convertino, Martina Del Lungo, Cristina Di Mauro, Gabriella Farina, Sara Ferraro, Annamaria Fucile, Elena Galfrascoli, Elisabetta Geninatti, Linda Giovannetti, Luca Leonardi, Rosa Liccardo, Anna Marra, Eleonora Marrazzo, Giovanna Monina, Silvia Pagani, Maria Parrilli, Concetta Rafaniello, Francesco Rossi, Marco Rossi, Stefania Rostan, Marco Ruocco, Marita Sironi, Giulia Spada, Liberata Sportiello, Giuditta Violetta Vighi, Lombardi, N., Crescioli, G., Bettiol, A., Tuccori, M., Capuano, A., Bonaiuti, R., Mugelli, A., Venegoni, M., Vighi, G. D., Vannacci, A., Aiezza, M. L., Bettoni, D., Blandizzi, C., Borsi, V., Cecchi, E., Convertino, I., Del Lungo, M., Di Mauro, C., Farina, G., Ferraro, S., Fucile, A., Galfrascoli, E., Geninatti, E., Giovannetti, L., Leonardi, L., Liccardo, R., Marra, A., Marrazzo, E., Monina, G., Pagani, S., Parrilli, M., Rafaniello, C., Rossi, F., Rossi, M., Rostan, S., Ruocco, M., Sironi, M., Spada, G., and Sportiello, L.
- Subjects
0301 basic medicine ,medicine.medical_specialty ,drug safety ,emergency department ,Population ,Context (language use) ,03 medical and health sciences ,seriousness ,0302 clinical medicine ,preventability ,Pharmacovigilance ,Medicine ,Pharmacology (medical) ,education ,adverse drug event ,Original Research ,Pharmacology ,education.field_of_study ,business.industry ,lcsh:RM1-950 ,Retrospective cohort study ,Odds ratio ,Emergency department ,Confidence interval ,030104 developmental biology ,lcsh:Therapeutics. Pharmacology ,adverse drug events ,hospitalization ,pharmacovigilance ,030220 oncology & carcinogenesis ,Emergency medicine ,Observational study ,business - Abstract
Background Adverse drug event (ADEs) are a significant cause of emergency department (ED) visits and consequent hospitalization. Preventing ADEs and their related ED visits in outpatients remains a public health safety challenge. In this context, the aims of the present study were to describe the frequency, seriousness and preventability of outpatients' ADE-related ED visits and hospitalizations in the Italian general population, and to identify the presence of potential predictors of ADE-related hospitalization. Methods We performed a nationwide, multicentre, observational, retrospective study based on reports of suspected ADEs collected between January 1, 2007 and December 31, 2018 in 94 EDs involved in the MEREAFaPS project. Patients' demographic characteristics, their clinical status, suspected and concomitant drugs, ADE description, and its degree of seriousness, were collected. Causality and preventability were assessed using validated algorithms, and logistic regression analyses were used to estimate the reporting odds ratios (RORs) with 95% confidence intervals (CIs) of ADE-related hospitalization, considering the following covariates: age, sex, ethnicity, number of implicated medications, parenteral administration, presence of interaction, therapeutic error, and/or complementary and alternative medicines (CAM). Results Within 12 years, 61,855 reports of suspected ADE were collected, of which 18,918 (30.6%) resulted in hospitalization (ADE defined as serious). Patients were mostly female (56.6%) and Caucasians (87.7%), with a mean age of 57.5 ± 25.0 years. 58% of patients were treated with more than two drugs, and 47% of ADEs leading to hospitalization were preventable. Anticoagulants, antibiotics, and nonsteroidal anti-inflammatory drugs (NSAIDs) were the most frequently implicated agents for ED visits and/or hospitalization, which included clinically significant ADEs, such as haemorrhage for anticoagulants, moderate to severe allergic reactions for antibiotics, and dermatologic reactions and gastrointestinal disturbances for NSAIDs. Older age (1.54 [1.48-1.60]), higher number of concomitantly taken drugs (2.22 [2.14-2.31]), the presence of drug-drug interactions (1.52 [1.28-1.81]), and therapeutic error (1.54 [1.34-1.78]), were significantly associated with an increased risk of hospitalization. Conclusion Our long-term active pharmacovigilance study in ED provided a valid estimation of ADE-related hospitalization in a representative sample of the Italian general population and can suggest further focus on medication safety in outpatients, in order to early recognise and prevent ADEs.
- Published
- 2020
13. Clinical research in paediatrics: what can we do?
- Author
-
Pugi A, Borsi V, Fabbiano A, and Leo MC
- Subjects
- Humans, Biomedical Research ethics, Drug-Related Side Effects and Adverse Reactions, Informed Consent ethics, Parental Consent ethics
- Published
- 2015
- Full Text
- View/download PDF
14. Probing the interaction of distamycin A with S100β: the "unexpected" ability of S100β to bind to DNA-binding ligands.
- Author
-
Cerofolini L, Amato J, Borsi V, Pagano B, Randazzo A, and Fragai M
- Subjects
- Binding Sites, Humans, Ligands, Models, Molecular, Protein Binding, Protein Structure, Tertiary, Distamycins chemistry, S100 Calcium Binding Protein beta Subunit chemistry
- Abstract
DNA-minor-groove-binding ligands are potent antineoplastic molecules. The antibiotic distamycin A is the prototype of one class of these DNA-interfering molecules that have been largely used in vitro. The affinity of distamycin A for DNA is well known, and the structural details of the complexes with some B-DNA and G-quadruplex-forming DNA sequences have been already elucidated. Here, we show that distamycin A binds S100β, a protein involved in the regulation of several cellular processes. The reported affinity of distamycin A for the calcium(II)-loaded S100β reinforces the idea that some biological activities of the DNA-minor-groove-binding ligands arise from the binding to cellular proteins., (Copyright © 2015 John Wiley & Sons, Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
15. Solution structure and dynamics of human S100A14.
- Author
-
Bertini I, Borsi V, Cerofolini L, Das Gupta S, Fragai M, and Luchinat C
- Subjects
- Binding Sites, Calcium chemistry, Copper chemistry, Humans, Light, Models, Molecular, Nuclear Magnetic Resonance, Biomolecular, Protein Binding, Protein Structure, Quaternary, Protein Structure, Secondary, Protein Structure, Tertiary, Scattering, Radiation, Surface Properties, Zinc chemistry, Apoproteins chemistry, Calcium-Binding Proteins chemistry
- Abstract
Human S100A14 is a member of the EF-hand calcium-binding protein family that has only recently been described in terms of its functional and pathological properties. The protein is overexpressed in a variety of tumor cells and it has been shown to trigger receptor for advanced glycation end products (RAGE)-dependent signaling in cell cultures. The solution structure of homodimeric S100A14 in the apo state has been solved at physiological temperature. It is shown that the protein does not bind calcium(II) ions and exhibits a "semi-open" conformation that thus represents the physiological structure of the S100A14. The lack of two ligands in the canonical EF-hand calcium(II)-binding site explains the negligible affinity for calcium(II) in solution, and the exposed cysteines and histidine account for the observed precipitation in the presence of zinc(II) or copper(II) ions.
- Published
- 2013
- Full Text
- View/download PDF
16. NMR characterization of the C-terminal tail of full-length RAGE in a membrane mimicking environment.
- Author
-
Borsi V, Cerofolini L, Fragai M, and Luchinat C
- Subjects
- Amino Acid Sequence, Cell Membrane chemistry, Cytoplasm chemistry, Cytoplasm metabolism, Humans, Molecular Sequence Data, Nuclear Magnetic Resonance, Biomolecular, Protein Structure, Tertiary, Receptor for Advanced Glycation End Products metabolism, Receptor for Advanced Glycation End Products chemistry
- Abstract
Targeting the receptor for the advanced glycation endproducts (RAGE) signalling has a potential for the prevention and treatment of several pathologies. Extracellular activation of RAGE triggers the interactions of the RAGE cytoplasmic tail with intracellular protein partners. Here the cytoplasmic tail of RAGE has been investigated by NMR as part of the full-length protein, in the presence of a membrane-mimicking environment. The isolated cytoplasmic tail has also been studied for comparison. The NMR spectra of the whole receptor show that some but not all residues belonging to the C-terminal region of the cytoplasmic tail have a large flexibility, while the membrane proximal region seems to be rigidly connected to the trans-membrane domain and ectodomains. The analysis indicates that the behavior of the cytoplasmic tail is strongly affected by its being part of the whole receptor. These results provide new insight towards the understanding of signal transduction by RAGE.
- Published
- 2012
- Full Text
- View/download PDF
17. Structural characterization of human S100A16, a low-affinity calcium binder.
- Author
-
Babini E, Bertini I, Borsi V, Calderone V, Hu X, Luchinat C, and Parigi G
- Subjects
- Amino Acid Sequence, Calcium-Binding Proteins chemistry, Calorimetry, Humans, Magnetic Resonance Spectroscopy, Molecular Sequence Data, Protein Structure, Secondary, Calcium-Binding Proteins metabolism, S100 Proteins chemistry, S100 Proteins metabolism
- Abstract
The homodimeric structure of human S100A16 in the apo state has been obtained both in the solid state and in solution, resulting in good agreement between the structures with the exception of two loop regions. The homodimeric solution structure of human S100A16 was also calculated in the calcium(II)-bound form. Differently from most S100 proteins, the conformational rearrangement upon calcium binding is minor. This characteristic is likely to be related to the weak binding affinity of the protein for the calcium(II) ions. In turn, this is ascribed to the lack of the glutamate residue at the end of the S100-specific N-domain binding site, which in most S100 proteins provides two important side chain oxygen atoms as calcium(II) ligands. Furthermore, the presence of hydrophobic interactions stronger than for other S100 proteins, present in the closed form of S100A16 between the third and fourth helices, likely make the closed structure of the second EF-hand particularly stable, so even upon calcium(II) binding such a conformation is not disrupted.
- Published
- 2011
- Full Text
- View/download PDF
18. Entropic contribution to the linking coefficient in fragment based drug design: a case study.
- Author
-
Borsi V, Calderone V, Fragai M, Luchinat C, and Sarti N
- Subjects
- Calorimetry, Catalytic Domain, Crystallography, X-Ray, Ligands, Magnetic Resonance Spectroscopy, Models, Molecular, Protein Binding, Drug Design, Entropy, Hydroxamic Acids chemistry, Matrix Metalloproteinase 12 chemistry, Matrix Metalloproteinase Inhibitors, Sulfonamides chemistry
- Abstract
For several drug leads obtained by tethering weak binding ligands, the dissociation constant is smaller than the product of those of the individual fragments by a factor named the linking coefficient, E. This favorable contribution is attributed to the entropic gain that is realized when two weak binding ligands are tethered. Here we show a case study where the linking coefficient is strikingly small (E = 2.1 x 10(-3) M(-1)) and its totally entropic nature is demonstrated.
- Published
- 2010
- Full Text
- View/download PDF
19. Global and local mobility of apocalmodulin monitored through fast-field cycling relaxometry.
- Author
-
Borsi V, Luchinat C, and Parigi G
- Subjects
- Apoproteins metabolism, Calmodulin metabolism, Magnetic Resonance Spectroscopy, Magnetics, Protons, Time Factors, Apoproteins chemistry, Calmodulin chemistry, Movement
- Abstract
Calmodulin (CaM) is a ubiquitous eukaryotic protein with two conformationally independent domains that can bind up to two calcium ions each. In the calcium-bound state, CaM is able to regulate a vast number of cellular activities by binding to a multiplicity of target proteins in different modes. Its versatility has been ascribed to its anomalously high flexibility. The calcium-free form (apoCaM), which is the resting state of CaM in cells, is also able to functionally bind a number of protein targets, but its dynamics has received less attention. At variance with the calcium-bound form, the crystal structure of apoCaM shows a compact organization of the two domains, but NMR measurements could not detect any contact between them, thus indicating the presence of mobility in solution. The mobility of apoCaM is here investigated through protein proton relaxation rate measurements performed with a high-sensitivity fast-field cycling relaxometer. Such measurements provide direct access to the spectral density function and show that 1), the reorientation time is in agreement with a closed form of the protein; but 2), the collective order parameter is much smaller than for other well folded compact proteins, indicating that a remarkably large side-chain mobility must be present.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.